What is BHRT?
Bioidentical hormones have the same molecular structure as hormones naturally produced by the human body. Depending on a person’s needs, treatment may involve :

Estradiol, the principal form of estrogen used in menopausal hormone therapy.
Micronised progesterone.
Testosterone, in carefully selected situations.
DHEA, when clinically appropriate.

Thyroid hormones, which are assessed and managed separately when a thyroid disorder is present.
These hormones may be prescribed in different forms, including creams, capsules . The safest and most effective option depends on the hormone being used, the symptoms being treated, medical history and individual risk profile.

It is also important to understand that “bioidentical” does not automatically mean “natural,” risk-free or superior. Some bioidentical hormone products are regulated, standardised medicines; others are individually compounded. When a suitable regulated product is available, major medical organisations generally prefer it because its dose, purity, effectiveness and safety are more consistently evaluated.

Why hormones matter.
Hormones work as a coordinated network rather than in isolation.

Estrogen supports expansion and vitality. It plays an important role in temperature regulation, vaginal and urinary tissue health, bone maintenance and several aspects of brain and metabolic function.

Progesterone provides stability. In anyone with a uterus who uses systemic estrogen, adequate progesterone or another appropriate progestogen is usually essential to protect the uterine lining. Micronised progesterone may also influence sleep and calmness in some people, although individual responses vary.

Testosterone supports strength, recovery and sexual wellbeing. Women naturally produce testosterone too, and men also require appropriate estrogen and progesterone activity. Hormonal health is not about maximising one hormone; it is about restoring an appropriate physiological balance.

DHEA is a precursor hormone. The body can convert it into other sex hormones. Supplementation is not suitable for everyone and should be based on clinical assessment rather than used routinely.

Who may benefit from an assessment?
An evaluation may be helpful if you are experiencing persistent symptoms during perimenopause, menopause, premature or surgical menopause, or another clinically confirmed hormone-deficient state.

Symptoms may include:

Hot flushes or night sweats.
Disturbed sleep.
Vaginal dryness, irritation or discomfort during intimacy.
Recurrent urinary symptoms.
Changes in mood or emotional wellbeing.
Reduced sexual desire.
Fatigue or reduced vitality.
Difficulty concentrating or a sense of “brain fog”.
Changes in muscle strength or body composition.
Accelerated bone loss or increased fracture risk.

These symptoms are not always caused by hormone deficiency. Thyroid dysfunction, iron or vitamin deficiencies, insulin resistance, medication effects, sleep disorders, depression, anxiety and other medical conditions can look similar. A careful assessment helps us understand what is actually driving the problem.

Potential benefits of menopausal hormone therapy
For an appropriately selected patient, hormone therapy is the most effective treatment for menopausal issues. It can help:
Hot Flushes , Night Sweats, Low Energy and Fatigue.
Improve menopause-related sleep disruption.
Relieve vaginal dryness and discomfort.
Support vulval, vaginal and urinary tissue health.
Reduce pain during intimacy when caused by estrogen deficiency.
Help prevent menopause-associated bone loss and fractures while treatment is continued.
Weight Issues and Water retention issues.
Improve quality of life when symptoms are meaningfully disruptive.
Low-dose vaginal estrogen may be recommended when symptoms are mainly vaginal or urinary. Because it acts locally and has minimal systemic absorption, its risk profile differs from systemic hormone therapy.

BHRT is not a weight-loss treatment, a cure for ageing or a guaranteed solution for every symptom. It should not be promoted as a proven way to prevent dementia, heart disease or cancer. Any broader health effects depend on the person, timing, formulation, dose and duration of treatment.

Our personalised BHRT pathway.
1) Detailed consultation :
We begin by understanding your symptoms, menstrual and reproductive history, sleep, stress, sexual health, nutrition, activity, medications, supplements, personal medical history and family history.

2) Risk and health assessment :
Before treatment, we assess factors such as unexplained bleeding, blood-pressure control, migraine pattern, cardiovascular and clotting risk, liver health, breast health, uterine history and any personal or family history of hormone-sensitive cancer.

3) Relevant investigations :
Testing is selected according to age, symptoms and clinical context. It may include thyroid markers, blood count, iron status, glucose regulation, lipids, liver function, vitamin D and selected hormone measurements.

In women over 45 with typical perimenopausal symptoms, a single hormone result is often not required to diagnose perimenopause because levels can fluctuate significantly. Tests are used when they can clarify the diagnosis, exclude another cause or safely guide treatment—not simply to generate a large panel.

4) Individualised treatment :
If BHRT is appropriate, the hormone, dose and delivery method are chosen specifically for you. For example :
Transdermal estradiol through the skin may be preferred in some women because it generally has a lower blood-clot risk than oral estrogen.
If the uterus is present, systemic estrogen usually needs to be paired with adequate progesterone or another suitable progestogen.
Local vaginal estrogen may be sufficient when symptoms are limited to vaginal or urinary tissues.
Testosterone may be considered for most perimenopausal women and selected postmenopausal women with persistent, distressing low sexual desire, osteoporosis, poor muscle recovery and exercise tolerance after other contributing factors have been evaluated. It is not routinely prescribed for general fatigue, weight loss or “anti-ageing.”

5) Review and monitoring :
An early review is commonly planned within approximately 6–12 weeks, depending on the treatment and clinical situation. We assess symptom response, side effects, adherence, blood pressure and any relevant laboratory or screening results. Once stable, treatment is reviewed periodically, usually at least annually, with earlier review if symptoms change.
Hormone therapy should remain an active shared decision. There is no universal fixed duration: continued use depends on ongoing benefit, evolving risks and personal preference.

Is BHRT safe?
BHRT can be appropriate and effective for many people, but no hormone treatment is completely risk-free.
The balance of benefit and risk is often most favourable for healthy women who begin menopausal hormone therapy in perimenopause as early as possible or within 10 years of menopause, provided they do not have contraindications. This is a general principle, not an automatic eligibility rule.

Risks vary with :
Age and time since menopause.
Personal and family medical history.
Whether the uterus is present.
Hormone type, dose, route and duration.
Smoking, blood pressure, metabolic health and clotting risk.
Breast, uterine, ovarian, cardiovascular and liver history.
Quality of the hormone prescribed e.g Synthetic Versus Bioidentical.

The exact risk is not the same for every regimen. Synthetic Estrogen without adequate uterine protection can increase the risk of endometrial hyperplasia and cancer in someone who has a uterus.In such cases bioidentical Progesterone is of Much Use.

Systemic and synthetic hormone therapy may not be appropriate—or may require specialist input—in people with unexplained vaginal bleeding, certain previous or active hormone-sensitive cancers, previous blood clots, stroke, heart attack, significant liver disease or other high-risk conditions.

Seek prompt medical advice for new or heavy vaginal bleeding, a breast lump, severe headache, chest pain, shortness of breath, coughing blood, one-sided leg pain or swelling, weakness, facial drooping or difficulty speaking.

The Kiiran Patel Wellness Cube approach
We believe hormonal care should be informed, measured and deeply personal.
No guessing: symptoms and clinical context guide meaningful investigations.
No one-size-fits-all protocols: the right hormone and dose differ from person to person.
Whole-person assessment: thyroid health, metabolic health, nutrition, sleep, stress and movement are considered alongside sex hormones.
Ongoing monitoring: treatment is reviewed every few days for both effectiveness and safety.
Clear conversations: potential benefits, limitations, alternatives and risks are discussed before treatment begins.

Add years to your life and life to your years.

Ready to understand your hormones better?
Book a personalised hormone-health consultation with Kiiran Patel Wellness Cube. Together, we can explore what is changing, rule out other causes and decide whether BHRT—or a non-hormonal approach—is right for you.